Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Noel Clarke, M.D.
Christie Hospital Foundation Trust
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
132 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Box Hill, Australia
- Research Site
Darlinghurst, Australia
- Research Site
Greenslopes, Australia
- Research Site
Herston, Australia
- Research Site
Kingswood, Australia
- Research Site
Kurralta Park, Australia
- Research Site
St Albans, Australia
- Research Site
Waratah, Australia
- Research Site
Ghent, Belgium
- Research Site
Belo Horizonte, Brazil
- Research Site
Curitiba, Brazil
- Research Site
Fortaleza, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Rio de Janeiro, Brazil
- Research Site
São José do Rio Preto, Brazil
- Research Site
São Paulo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Calgary, Alberta, Canada
- Research Site
Edmonton, Alberta, Canada
- Research Site
Kelowna, British Columbia, Canada
- Research Site
Halifax, Nova Scotia, Canada
- Research Site
London, Ontario, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Greenfield Park, Quebec, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Santiago, Chile
- Research Site
Santiago, Chile
- Research Site
Temuco, Chile
- Research Site
Viña del Mar, Chile
- Research Site
Brno, Czechia
- Research Site
Prague, Czechia
- Research Site
Prague, Czechia
- Research Site
Prague, Czechia
- Research Site
Angers, France
- Research Site
Besançon, France
- Research Site
Caen, France
- Research Site
Pierre-Bénite, France
- Research Site
Quimper, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2018
- Primary completion
- 30 Jul 2021
- Completion
- 5 Feb 2027
- Last update posted
- 2 Jun 2026
- Registered enrollment
- 895
- Registry id
- NCT03732820
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.